Case of Application of Syrolimus in a Patient with Progressing Pultifocal Pepatic Nodular Hyperplasia

 

Abstract

Introduction: A case presented to the public demonstrates the possibility of treatment with Sirolimus in a patient with progressive multifocal liver Focal Nodular Hyperplasia (FNH) with progressive growth and a tendency to formation of liver function insufficiency after splenorenal shunt for portal hypertension.

Material and Methods: Patient E. 08.03.2001 year of birth c Diagnosed with multifocal bilobar nodular liver hyperplasia after splenorenal bypass surgery for portal hypertension, established in 2018/ Sirolimus treatment was prescribed from 06.22.18 to the present.

Conclusion: As a result of the treatment with Sirolimus, a normalization of the level of liver enzymes, bilirubin in the blood is noted. According to radiation methods, a reduction in liver size and FNH size is up to 30%.

Read more about this article: https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/case-of-application-of-syrolimus-in-a-patient-with-progressing-pultifocal-pepatic-nodular-hyperplasia.ID.000153.php

Read about Lupine Publishers Google Scholar Articles: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=XbnlB50AAAAJ&cstart=400&pagesize=100&citation_for_view=XbnlB50AAAAJ:9LpHyFPp1DQC

Comments

Popular posts from this blog

Food Sources and Bioavailability of Calcium

Different Toxicity of Aristolochic Acids in Kidney and Liver

May Gastrointestinal and Sensory Manifestations be related to Worse COVID-19 Phenotypes